Principia Biopharma Funding & Investors
South San Francisco, CA
Principia Biopharma Inc. operates as a clinical stage biopharmaceutical company. The Company offers reversible covalent small molecule drugs for the treatment of cancers. Principia Biopharma serves patients in the United States.
principiabio.comTotal Amount Raised: $337,799,968
Principia Biopharma Funding Rounds
Post Ipo Equity
$210,000,000
Series Unknown
$49,999,978
Series Unknown Investors
Mission BioCapitalIPO
Unknown
Series B
$15,300,000
Series B Investors
OrbiMed AdvisorsNew Leaf Venture PartnersMorgenthalerBaker Bros. AdvisorsSofinnovaSr OneSeries B
$50,000,000
Series B Investors
SofinnovaMorgenthalerNew Leaf Venture PartnersSr OneMission Bay CapitalOrbiMed AdvisorsSeries A
$12,500,000
Series A Investors
New Leaf Venture PartnersOrbiMed AdvisorsMorgenthalerMission Bay CapitalSr One
Funding info provided by Diffbot.